Please login to the form below

Not currently logged in
Email:
Password:

MK-3102

This page shows the latest MK-3102 news and features for those working in and with pharma, biotech and healthcare.

Merck & Co enters $430m diabetes deal with Abide

Merck & Co enters $430m diabetes deal with Abide

Merck also has a Januvia follow-up in development, with phase IIb data suggesting that MK-3102 could offer a similar level of effectiveness, but at a once-weekly rather than

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...